VERACYTE INC (VCYT)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for VCYT
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| VCYT | Member | ["Senior Leadership","Diagnostics","Biopharma","U.S. Healthcare Reimbursement","Global Enterprise","Accounting and Auditing (including Sustainability Reporting)","Public Board","Technology, Innovation and AI","Cybersecurity","Regulatory and Risk Oversight","Commercialization and Market Access","Sales and Marketing"] | ["Regulatory and Compliance Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Tom Miller, Ph.D. , has served on our Board of Directors since September 2024. Dr. Miller is a scientist and entrepreneur with a focus on the nexus of AI, chemistry and biology. Since 2020, he has served as Co-founder and Chief Executive Officer of Iambic Therapeutics, a clinical-stage biotechnology company that is disrupting the therapeutics landscape with a unique, AI-driven, drug-discovery platform. Prior to this, he served for over ten years as a professor at the California Institute of Technology (Caltech), receiving tenure, publishing over 140 peer-reviewed articles and patents, and receiving numerous awards for research and entrepreneurial excellence. Dr. Miller earned a B.S. in Chemistry and Mathematics from Texas A&M University and a Ph.D. in Theoretical Chemistry from the University of Oxford. We believe that Dr. Miller is qualified to serve on our Board of Directors due to his expertise in AI, emerging technologies and data analytics. Age: 47 Director Since: 2024 Committees: Regulatory and Compliance